Pulse Journal Club Active Debates Trending Explore Questions Researchers

Download the App

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

© Synapse Social LLC, 2026

Home Explore Journal Club Trending

⌘+K

Longer-Term All-Cause and Cardiovascular Mortality With Intensive Blood Pressure Control | Synapse

October 12, 2022Open Access

Longer-Term All-Cause and Cardiovascular Mortality With Intensive Blood Pressure Control

Key Points

Key points are not available for this paper at this time.

Abstract

ClinicalTrials.gov Identifier: NCT01206062.

Read Full Paperexternally

Mark Helpful

Bookmark

Relay

View Full Paper

Mark Helpful

Bookmark

Relay

View Full Paper

Cite This Study

Jaeger et al. (Wed,) studied this question.

synapsesocial.com/papers/69d7332e5f9a1dad5348f432 https://doi.org/https://doi.org/10.1001/jamacardio.2022.3345

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Legacy effect in medicine—the expanding horizon!2018 · 6 citations
2Rise in Blood Pressure Observed Among US Adults During the COVID-19 Pandemic2021 · 156 citations
3Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: an individual participant-level data meta-analysis2021 · 322 citations
4The design and rationale of a multicenter clinical trial comparing two strategies for control of systolic blood pressure: The Systolic Blood Pressure Intervention Trial (SPRINT)2014 · 546 citations
5Dynamic Regression Models for Survival Data2007 · 312 citations